Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 257 participants.
Also called NCT05431972
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 257 participants
- Sponsor
- Registry
-
NCT05431972
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05431972. Randomized; no masking; primary purpose diagnostic. Start 2022-11-01 (actual); primary completion 2024-09-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement
- Condition
- Embolic Stroke of Undetermined Source
- Intervention (Device)
- Cardea SOLO
- Intervention (Device)
- 12 Lead EKG
- Lead sponsor
- Asan Medical Center
Record details
- Record id
cardio:ct-nct05431972- Content hash
34dde06c8a96792320f82837f49e4b8e7eb78ccbd6e117966c25b021850257f0